BMY
BRISTOL-MYER SQB
Health Care·Pharmaceuticals·UNITED STATES
$65.47
MCap $133.7B
as of 2026-08-20
Total
B4w
Fund
C9w
Quant
A1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.51
Sentiment 81.7%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$65.47
Adaptive Mean
$66.25
-0.78 vs mean
Adaptive σ
0.76
MIDOS BB
$64.73 – $67.77
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.16
ROE
46.6%
Z +0.90
Rev Gr
5.7%
Z -0.28
EPS Gr
153.1%
Z +0.04
OPM Gr
0.3%
Z -0.38
FCF Yld
6.0%
Z +0.67
EPS Surp
0.3%
Z +0.03
EPS 3mo Δ
6.3%
Z +0.15
Fwd P/E
10.02
Z —
PEGY
0.02
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
8.92
Q6M
2.99
Q12M
6.60
MA 30/100
1.064
Bullish (MA30 > MA100)
α (Jensen)
0.4580
β (12M)
0.24
σ (12M)
0.274
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
76%
Q Percentile
86%
Divergence
-10.4
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-3.3
RS Pctl
56%
RS Decile
D6
Persistence
4w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.